EUVIMEDOpdag EUVIMED
KohortenstudieOpen access

Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study

Yingxin Liu iD, Ruoting Wang iD, Shuai Li iD, Changfa Zhang iD, Gregory Y H Lip iD, Lehana Thabane iD, Guowei Li iD

JMIR Public Health and Surveillance · 2024-01-31 · 10 · e50415

DOI: 10.2196/50415 ↗

At a glance

Kohortenstudie in JMIR Public Health and Surveillance, published online on 2024-01-31. Written by Yingxin Liu and 6 co-authors. Institution: Center for Clinical Epidemiology and Methodology, Guangdong Second Provincial General Hospital, Guangzhou, China. Major MEDLINE topics: Cardiovascular Diseases, Renal Insufficiency, Chronic. Cited 17 times so far (Crossref); 50 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Chronic kidney disease (CKD) poses a significant global public health challenge. While lipoprotein(a) (Lp[a]) has been established as a significant factor in cardiovascular disease, its connection to CKD risk remains a topic of debate. Existing evidence indicates diverse risks of kidney disease among individuals with various renal function indicators, even when within the normal range.

Objective

This study aims to investigate the joint associations between different renal function indicators and Lp(a) regarding the risks of incident CKD in the general population.

Methods

The analysis involved a cohort of 329,415 participants without prior CKD who were enrolled in the UK Biobank between 2006 and 2010. The participants, with an average age of 56 (SD 8.1) years, included 154,298/329,415 (46.84%) males. At baseline, Lp(a) levels were measured using an immunoturbidimetric assay and classified into 2 groups: low (

Subjects

MeSH terms (MEDLINE)

Cardiovascular DiseasesRenal Insufficiency, ChronicMaleHumansMiddle AgedFemaleLipoprotein(a)Prospective StudiesKidney

Author keywords

chronic kidney diseaseglomerular filtration ratelipoprotein(a)renal functionurinary albumin-to-creatinine ratio

Substances

Lipoprotein(a)

Authors and institutions

  • Center for Clinical Epidemiology and Methodology, Guangdong Second Provincial General Hospital, Guangzhou, China.
  • Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
  • Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
  • Father Sean O'Sullivan Research Centre, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.

ORCID profiles: Yingxin Liu, Ruoting Wang, Shuai Li, Changfa Zhang, Gregory Y H Lip, Lehana Thabane, Guowei Li

Cite

APA

Liu, Y., Wang, R., Li, S., Zhang, C., Lip, G. Y. H., Thabane, L., & Li, G. (2024). Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study. JMIR Public Health and Surveillance, 10, e50415. https://doi.org/10.2196/50415

Vancouver

Liu Y, Wang R, Li S, Zhang C, Lip GYH, Thabane L, et al. Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study. JMIR Public Health and Surveillance. 2024;10:e50415. doi:10.2196/50415

BibTeX
@article{Liu2024,
  author = {Liu, Yingxin and Wang, Ruoting and Li, Shuai and Zhang, Changfa and Lip, Gregory Y H and Thabane, Lehana and Li, Guowei},
  title = {Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study},
  journal = {JMIR Public Health and Surveillance},
  year = {2024},
  volume = {10},
  pages = {e50415},
  doi = {10.2196/50415}
}
Start for free →